Benefit of erlotinib in patients with non-small-cell lung cancer is related to smoking status, gender, skin rash and radiological response but not to histology and treatment line (Q43044776)
Jump to navigation
Jump to search
scientific article published on 4 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Benefit of erlotinib in patients with non-small-cell lung cancer is related to smoking status, gender, skin rash and radiological response but not to histology and treatment line |
scientific article published on 4 June 2010 |
Statements
1 reference
Benefit of erlotinib in patients with non-small-cell lung cancer is related to smoking status, gender, skin rash and radiological response but not to histology and treatment line (English)
1 reference
Martin Faehling
1 reference
Robert Eckert
1 reference
Sabine Kuom
1 reference
Torsten Kamp
1 reference
Kathrin M Stoiber
1 reference
Christian Schumann
1 reference
4 June 2010
1 reference
1 reference
78
1 reference
3-4
1 reference
249-258
1 reference
Identifiers
1 reference
1 reference